> 首页 > 产品 > 一抗 > 其他 > Anti-IL-17a & IL-17f Reference Antibody (afasevikumab)

Anti-IL-17a & IL-17f Reference Antibody (afasevikumab)

Anti-IL-17a & IL-17f Reference Antibody (afasevikumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-IL-17a & IL-17f Reference Antibody (afasevikumab) is 100%, determined by SEC-HPLC.
Immobilized N-Fc(mIgG2a)-hIL-17F at 2 µg/mL can bind afasevikumab, EC50= 0.003765 µg/mL.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession	Q16552 & Q96PD4
Reactivity	Human
Clonality	Monoclonal
Isotype	IgG1-REM

Additional Information
Target/Specificity	IL-17a & IL-17f
Expression system	CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.